Precision Oncology in Melanoma and Skin Cancer Surgery

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Metastatic melanoma prognosis has seen significant improvement over the past decade.
• This progress is linked to a deeper understanding of melanoma tumor biology.
• Key advancements stem from identifying therapeutically relevant driver mutations and understanding tumor-specific immune responses.

Purpose of the Study:

• To highlight the recent breakthroughs in metastatic melanoma treatment.
• To explain how understanding tumor biology and immune response has personalized therapy.
• To underscore the rapid advancements in managing this solid tumor.

Main Methods:

• Review of recent scientific literature on melanoma treatment.
• Analysis of key findings in cancer genetics and immunology related to melanoma.
• Synthesis of information on personalized medicine approaches in oncology.

Main Results:

• Identification of specific driver mutations in melanoma has enabled targeted therapies.
• Mechanistic insights into the tumor immune response have paved the way for immunotherapy.
• These combined advances have led to a paradigm shift towards personalized treatment for metastatic melanoma.

Conclusions:

• The prognosis for metastatic melanoma has dramatically improved due to personalized treatment strategies.
• Targeted therapies and immunotherapies, driven by molecular and immunological understanding, are revolutionizing patient care.
• Continued research into melanoma tumor biology promises further advancements in patient outcomes.